-
Patent Agency Ranking
1.发明授权公开(公告)号：US09963466B2
公开(公告)日：2018-05-08
申请号：US15452686
申请日：2017-03-07
Applicant: Vanderbilt University
Inventor： Heidi E. Hamm , Shaun R. Stauffer , Craig W. Lindsley , Matthew T. Duvernay , Kayla J. Temple
IPC: C07D513/04
CPC classification number: C07D513/04
Abstract: Embodiments of the invention include compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
-
2.发明申请公开(公告)号：US20170253617A1
公开(公告)日：2017-09-07
申请号：US15452686
申请日：2017-03-07
Applicant: Vanderbilt University
Inventor： Heidi E. Hamm , Shaun R. Stauffer , Craig W. Lindsley , Matthew T. Duvernay , Kayla J. Temple
IPC: C07D513/04
CPC classification number: C07D513/04
Abstract: Embodiments of the invention include compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
-
公开(公告)号：US20190119300A1
公开(公告)日：2019-04-25
申请号：US16094822
申请日：2017-04-17
Applicant: Vanderbilt University
Inventor： Heidi E. Hamm , Shaun R. Stauffer , Craig W. Lindsley , Matthew T. Duvernay , Kayla J. Temple
IPC: C07D513/04 , A61P31/16
Abstract: Embodiments of the invention include compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
-
4.发明授权Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists 有权取代的吲哚作为选择性蛋白酶活化受体4（PAR-4）拮抗剂公开(公告)号：US09572794B2
公开(公告)日：2017-02-21
申请号：US14820488
申请日：2015-08-06
Applicant: Vanderbilt University
Inventor： Heidi E. Hamm , Shaun R. Stauffer , Craig W. Lindsley , Wandong Wen , Summer E. Young , Matthew T. Duvernay , Kayla J. Temple
IPC: A61K31/404 , A61K31/407 , A61K31/437 , C07D209/10 , C07D209/30 , C07D239/00 , C07D401/04 , C07D513/04 , A61K31/4985 , A61K31/519 , A61K31/5025 , C07D221/00 , C07D237/00 , C08L67/02 , C08L69/00
CPC classification number: A61K31/407 , A61K31/404 , A61K31/437 , A61K31/4985 , A61K31/5025 , A61K31/519 , C07D209/10 , C07D209/30 , C07D221/00 , C07D237/00 , C07D239/00 , C07D401/04 , C07D513/04 , C08K5/42 , C08L67/02 , C08L69/00 , C08L2205/02
Abstract: Embodiments of the invention include substituted indole compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
Abstract translation: 本发明的实施方案包括取代的吲哚化合物及其组合物以抑制蛋白酶活化的受体-4。 还描述了通过施用组合物来制备治疗与血栓形成障碍有关的疾病的组合物和方法的方法。
-
5.发明申请Substituted Indoles as Selective Protease Activated Receptor 4 (PAR-4) Antagonists 有权取代的吲哚作为选择性蛋白酶活化受体4（PAR-4）拮抗剂公开(公告)号：US20160083363A1
公开(公告)日：2016-03-24
申请号：US14820488
申请日：2015-08-06
Applicant: Vanderbilt University
Inventor： Heidi E. Hamm , Shaun R. Stauffer , Craig W. Lindsley , Wandong Wen , Summer E. Young , Matthew T. Duvernay , Kayla J. Temple
IPC: C07D401/04 , C07D513/04
CPC classification number: A61K31/407 , A61K31/404 , A61K31/437 , A61K31/4985 , A61K31/5025 , A61K31/519 , C07D209/10 , C07D209/30 , C07D221/00 , C07D237/00 , C07D239/00 , C07D401/04 , C07D513/04 , C08K5/42 , C08L67/02 , C08L69/00 , C08L2205/02
Abstract: Embodiments of the invention include substituted indole compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
Abstract translation: 本发明的实施方案包括取代的吲哚化合物及其组合物以抑制蛋白酶活化的受体-4。 还描述了通过施用组合物来制备治疗与血栓形成障碍有关的疾病的组合物和方法的方法。
-
-
-
-
Search Results
5
records
(took 0.023 seconds)
